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Ying Wang and Bruce Rannala
Genome Center and Section of Evolution and Ecology, University of California Davis, Davis
We present a new method for simulating samples of marker haplotypes, genotypes, or diplotypes in case-control
studies in which the markers are linked to a disease locus in any specified region of the genome. The method allows
realistic features to be incorporated into the simulations, including selection acting on disease alleles, sample
ascertainment of disease chromosomes and polymorphic markers, a genetic dominance model of disease expression
that allows incomplete penetrance and phenocopies, and an accurate genetic map of recombination rates and
hotspots for recombination in the human genome (or, alternatively, an improved method for simulating the dis-
tribution of hotspots). The new method uses an approach that combines simulation of the coalescent process for
the sampled chromosomes with a diffusion process used to model the evolution of the disease-mutation frequency
over time. Examples illustrate how the method may be used to study the expected power of a marker-disease
association study.
Recent initiatives such as the International HapMap Pro-
ject, as well as expanding databases of mapped SNPs
(dbSNP) and microsatellite polymorphisms (Marshfield
Center for Medical Genetics), have created opportunities
for large-scale association studies to map human disease
loci with the use of unrelated cases and controls. To
examine the power of particular mapping strategies, a
comprehensive simulation program is needed that allows
samples of haplotypes, genotypes, or diplotypes to be
generated under realistic conditions. Here, we present a
new simulation methodology that has been developed
for this purpose. The method combines a coalescent pro-
cess (which is used for modeling the genealogy under-
lying a sample of chromosomes from cases and controls)
and a diffusion process (which is used for modeling the
evolutionary history of the frequency of a disease mu-
tation), and it allows for the incorporation into simu-
lation studies of additional features that are very im-
portant in human populations (and human disease stud-
ies) but that have been neglected by past simulation meth-
odologies. New features include sample ascertainment
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of disease chromosomes and polymorphic markers, a
genetic dominance model of disease expression that al-
lows incomplete penetrance and phenocopies, and an
accurate genetic map of recombination rates and hot-
spots for recombination in the human genome (or, al-
ternatively, an improved method for simulating the dis-
tribution of hotspots).
Several programs have been developed recently to sim-
ulate samples of chromosomes under either a neutral
Fisher-Wright model (Hudson 2002; Posada and Wiuf
2003) with recombination and genetic drift or a model
with selection acting on a specified locus (Spencer and
Coop 2004). These methods are perfectly adequate for
simulating a random sample of chromosomes from a
large population. However, in case-control association
studies, linkage disequilibrium mapping studies, and
other disease-gene mapping contexts, the sample is high-
ly nonrandom. Ascertainment of individuals that exhibit
a disease enriches the sample for an underlying disease
mutation, increasing its frequency in the sample, relative
either to that in the population or to that expected in a
random sample. Zo¨llner and von Haeseler (2000) de-
veloped a method for simulating the joint coalescent
structure for a neutral disease locus in cases and controls
in which all cases have exclusively disease-mutation–
bearing chromosomes and all controls have exclusively
normal chromosomes. This is suitable for modeling a
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Figure 1 A, The structure of a coalescent model with recombination, between a chromosomal segment descended from a disease mutation
at a given locus (left) and a sample of chromosomes not descended from the mutant (right). The alleles present at three diallelic marker loci
are indicated by “0” and “1” for the sampled chromosomes that are represented as vertical lines at the top of the figure. Ancestral chromosomes
involved in coalescence and recombination events are indicated by shaded and unshaded circles, respectively, on the ancestral recombination
graph, and mutation events are represented as crosses. Segments of chromosomes transmitted to descendent lineages from each of the two
ancestral lineages following a recombination event are represented as solid and broken horizontal lines. B, The distribution of recombination
rates over a chromosome, generated by one instance of a GBM simulation.
sample of cases and controls for a rare recessive disease,
for example. One drawback to their approach is that it
assumes that the population frequency of the disease
mutation has remained constant since it arose. Wang
and Rannala (2004) used a diffusion process to model
the evolution of the disease-allele frequency over time,
thus relaxing the assumption of a constant disease-mu-
tation frequency but retaining the assumption of a simple
Mendelian inheritance pattern and a neutral disease lo-
cus. The objective of the present study is to extend the
model of Wang and Rannala (2004) to allow both for
a complex model of inheritance for a disease locus and
for natural selection acting on the locus. We also incor-
porate more-realistic models of recombination hotspots
into our simulation procedure. Our approach builds on
earlier work by Kaplan et al. (1988) and Hudson and
Kaplan (1988), who focused primarily on modeling the
effects of deterministic selection on summary statistics
(such as the number of segregating sites) for a random
sample of chromosomes by use of a coalescent theory
framework.
A unique (nonrecurrent) mutation is assumed to arise
as a single copy at generation in the past (fig. 1A). A′T
present-day sample of chromosomes is generated by fix-
ing the age of the mutation ( ) and then simulating the′T
frequency of the mutation forward through time, con-
ditional on nonextinction, where pt is the frequency at
generation t in the past. Our method also allows one to
condition on the present-day allele frequency, p0, via
rejection sampling. For a neutral allele, the process of
random drift of the allele frequency can be simulated by
use of a diffusion approximation (e.g., Kimura and Ta-
kahata 1983). Given the sample path of the frequency
of the disease allele over time, ,pp {p , p , … , p }t t1 0
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Figure 2 Normal probability plot, constructed by use of con-
ditional distribution of normalized log recombination rates for the
Icelandic map data of Kong et al. (2002). The plot is based on marker
data obtained from the q arm of chromosome 2 in females. The more
linear the appearance of the plot, the better the fit to the GBM model.
the coalescent process with recombination is simulated
on the basis of an ancestral recombination graph with
variable population size among chromosomes2N pt t
carrying the mutation and with variable population size
among those not carrying the mutation2N (1 p)t t
(Wang and Rannala 2004). We assume a model of either
constant population size or continuous exponential
growth, but arbitrary population growth patterns can
be readily incorporated.
The waiting time until a coalescent event occurs in
the gene tree of either mutation-bearing chromosomes
or normal chromosomes is simulated using a discrete-
time model (with time measured in units of generations),
rather than the more usual continuous-time model. To
efficiently simulate the waiting times on a discrete-time
scale, a recursion strategy is used (Wang and Rannala
2004). At times after the origin of the mutation, mutant
chromosomes only coalesce with one another, as do the
normal chromosomes. Recombination can occur both
within and between genealogies of the mutant and nor-
mal chromosomes. If a homogeneous recombination
model is used, then the recombination breakpoints are
uniformly distributed along the chromosomal region.
Otherwise, recombination rates along the region either
are simulated using a geometric Brownian motion (GBM)
model (described below) or are extracted from the Ice-
landic recombination map data (Kong et al. 2002).
After the genealogy of the sample of the disease and
normal chromosomes is generated, mutations are su-
perimposed on it. Given the size of the chromosomal
interval and the mutation rate either for SNPs under a
Jukes-Cantor model or for STRP (microsatellite) mark-
ers under a stepwise mutation model (Ohta and Kimura
1973; Valdes et al. 1993), the number of mutations that
occur in the history of the sample at each site follows a
Poisson distribution. The numbers and the positions of
markers are treated as random variables, and the distri-
bution of the positions of mutations on branches of the
genealogy is uniform under a Poisson process model of
mutation (see Hudson 1990). Only polymorphic sites are
retained as potential markers. The evolution of the poly-
morphic sites is simulated forward in time. Because of
recombination or relatively younger mutations at marker
loci, some markers may be monomorphic or may have a
low polymorphism level. The markers that comprise the
sample are randomly chosen in accordance with a pre-
defined polymorphism cutoff level.
If a disease locus is under selection, the sample path
of the population frequency of the disease mutation is
instead generated by use of a diffusion model with se-
lection. The Kimura and Takahata (1983) procedure for
simulation of the sample path under neutral drift can be
modified to incorporate selection. The allele frequency
at the next generation, given the current frequency, is
normally distributed, with expectation and variance de-
termined by the diffusion model. The average change of
allele frequency per generation under selection (with se-
lection coefficient s 10) is , in accor-M p sp(1 p)dp
dance with a diffusion approximation (with no domi-
nance). If population size (N) is constant, the variance
of the change in allele frequency ( ) that results from2jdp
random drift is . If we assume that thep(1 p)/(2N)
population has grown exponentially with rate r to the
current population size (N0), then, at generation t in the
past, . Given the age and initial2 rtj p p(1 p)/(2N e )dp 0
frequency, , of the disease mutation, the
′rT1/(2N e )0
change of frequency is simulated by generating a uniform
random variable with mean and variance , con-2M jdp dp
ditional on nonextinction. If fewer than four copies of
the disease allele are present in the population, the dif-
fusion approximation is no longer accurate, and the
number of alleles in the next generation is instead sim-
ulated as a Poisson random variable (with parameter
per) by use of the branching-process approximation for
a rare allele (see Ewens 1979). The method can be ex-
tended to other selection models by simply replacing the
average rate of change of allele frequency under a dif-
fusion model.
Recent studies suggest that the human genome con-
sists of haplotype blocks (Phillips et al. 2003). This hap-
lotype-block structure is a consequence of population
processes as well as recombination hotspots, and, to ac-
curately model human haplotype structure, both pro-
cesses should be incorporated into the model. Recent
evidence suggests that recombination rates in humans
are higher near the telomeres and lower near the cen-
tromeres. The Icelandic recombination map displays a
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Figure 3 Expected power, as a function of sample size, of an
association study to detect a disease locus with either purely recessive
(A) or purely dominant (B) inheritance for markers positioned in three
different chromosomal intervals, with average distances of 1 kb (v1),
10 kb (v2), or 100 kb (v3) from the disease locus. The parameters
, , and were used for the simulations. The6N p 10 rp 0.01 sp 00
disease-mutation age was chosen to satisfy . A′T p 840 E(p)p 0.1
total of 5,000 replicate simulations were used to compute the expected
power.
large number of recombination rate peaks and valleys
distributed along each chromosome, with an increasing
trend in rates from centromere to telomere (Kong et al.
2002). We propose a new method that uses a GBM
model, with the recombination rate evolving over the
length of the chromosome, to simulate the distribution
of nonhomogeneous recombination rates along a chro-
mosomal region. The GBM process, also called “log-
normal growth,” is a particularly attractive model of
rate evolution because it assumes that changes of rate
are random but that the magnitude of such changes is
proportional to the current rate.
Under a GBM model, the log ratio of the recombi-
nation rate at one point on a chromosome, conditional
on the rate at the preceding point, follows a normal
distribution, with the mean and variance correlated with
the physical distance between the two points. If a GBM
model is used to simulate the distribution of recombi-
nation rates in this way, it implies that adjacent loci will
tend to have similar crossover rates, yet there exists a
stochastic deviation of rates between loci that depends
on the diffusion coefficient ( ) in the GBM process and2j
the physical distance between the two sites. If a GBM
process with drift ( ) is assumed, if the initial recom-m 1 0
bination rate is set to a relatively small value, and if re-
combination rates are always simulated from centromere
to telomere, then the process mimics the tendency for
recombination to be high near the telomere and low near
the centromere. An example of a simulated GBM process
of the evolution of recombination hotspots on a chro-
mosome is given in figure 1B.
The validity of the GBM model for the distribution
of recombination rates along a chromosome was ex-
amined by fitting the conditional distribution of the nor-
malized log rates at adjacent sites to a standard normal
distribution via a normal probability plot applied to the
data of Kong et al. (2002) (fig. 2). In the simulation
program, the default drift (m) and diffusion ( ) param-2j
eters are the average of the maximum-likelihood esti-
mator (MLE) over all autosomal chromosomes (pooling
females and males), calculated by using the data of
Kong et al. (2002). The MLEs are 8mp 3.074# 10
and , respectively. Other options in-2 8j p 2.503# 10
cluded in the program are uniform rates of recombi-
nation (e.g., 1 cMp 1 Mb) and rates of recombination
for any specified chromosomal interval obtained directly
from the Icelandic map (Kong et al. 2002).
Phenocopies, low penetrance, and other factors may
lead to a loss of power for identification of disease-mu-
tation location by use of association methods. The effect
of disease penetrance was incorporated into in our sim-
ulation procedure by using a standard three-parameter
penetrance model. At the disease-mutation locus, the dis-
ease-causing allele is denoted by “D,” and the alternative
allele is denoted by “N.” The probability that an indi-
vidual has a certain genotype at the disease locus (e.g.,
genotype DN), given that the individual expresses the
disease phenotype, is
f (DN) g(DN)Df(DNFaffected)p , (1) f (X) g(X)D
X
where represents the penetrance of a genotype atf (7)D
the disease locus and denotes the frequency of ag(7)
genotype. If we assume Hardy-Weinberg equilibrium at
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Table 1
Descriptions of Parameters and Variables Used in Simulation Studies
Parameter/Variable Description
nD and nN Numbers of affected and normal (control) individuals in the sample
N0 Current population size
r Exponential population growth rate
T Age (in generations) of the disease-susceptibility allele
p Population frequency of the disease-susceptibility allele
E(p) Expected population frequency of the disease-susceptibility allele
v(7) Marker location (in Mb)
s Selection coefficient
f(7) Disease-penetrance parameter of a genotype
f Disease prevalence
R(7) Genotype-specific disease risk relative to the homozygous (nonsusceptibility allele) genotype
the disease locus and if the population frequency (p) of
the disease mutation is known, equation (1) becomes
f(DNFaffected)p
f (DN) 2p(1 p)D .2 2f (DD)p  f (DN)2p(1 p) f (NN)(1 p)D D D
(2)
Similarly, the probability that an individual has a certain
genotype at the disease locus (e.g., genotype DN), given
that the individual does not express the disease phe-
notype, denoted by “ ,” can be ob-f(DNFunaffected)
tained by replacing in withf (DN) f(DNFaffected) 1D
. Conditional probabilities for other genotypesf (DN)D
can be calculated using the above equation, by substitut-
ing the corresponding penetrance and frequency terms.
Given the above conditional probabilities for two cat-
egories (cases and controls) and the number of indi-
viduals in these two categories, the distribution of the
counts of individuals in a sample with each genotype at
the disease locus will follow a multinomial distribution.
The distribution of the number of disease and normal
chromosomes in a sample is therefore completely spec-
ified by this sampling model. Genotypes are simulated
from the multinomial distribution defined by this model.
For example, the distribution of genotypes among nA
affected individuals is
nAf(n ,n ,n Fn )pDD DN NN A ( )n ,n ,nDD DN NN
nDD# f(DDFaffected)
nDN# f(DNFaffected)
nNN# f(NNFaffected) , (3)
where , for example, is the number of DD genotypesnDD
in a sample of nA affected individuals. Given the numbers
of disease-mutation–bearing chromosomes and normal
chromosomes in the sample (a simple function of the
genotype counts), the simulation methods discussed
above are used to generate a sample of disease and nor-
mal chromosomes that have multiple linked markers.
Here, we provide several examples of how our pro-
gram can be applied to examine the prospective power
of association studies to detect a mutation that contrib-
utes to a disease. Power is measured as the proportion
of replicate simulations for which the simulated case-
control genotype data show a significant marker-disease
association, as determined by a test of association2x
applied to genotypes, with the critical value set at
. The parameters and variables used in the sim-Pp .05
ulations are summarized in table 1.
Two penetrance models were considered in our sim-
ulation study: additive and multiplicative models. If,
for convenience, we define r and a as two intermediate
coefficients, then , , andf (DD)p 2r f (DN)p r aD D
for the additive model and ,2f (NN)p 2a f (DD)p rD D
, and for the multiplica-2f (DN) p ra f (NN) p aD D
tive model. Given 2fp f (DD)p  f (DN)2p(1 p)D D
and the relative disease risk for genotype2f (NN)(1 p)D
DD (denoted as “ ” [we define the risk relative toRDD









and the parameters r and a in a multiplicative model
are
frp (6)
1 12 2p  2p(1 p) (1 p)R RDD DD
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Figure 4 Expected power, as a function of genotype relative risk,
of an association study to detect a neutral disease-associated mutation,
computed by using markers positioned in three different chromosomal
intervals, with average distances of 1 kb (v1), 10 kb (v2), or 100 kb
(v3) from the disease locus. Power was estimated using simulated sam-
ples with and . A, Expected power, with an averagen p 100 n p 100D N
present-day population frequency of the disease mutation of pp
and a mutation age of 840 generations. B, Expected power, with0.1
an average present-day population frequency of the disease mutation
of and a mutation age of 600 generations.pp 0.01
and
1ap r . (7)
RDD
The results of our simulations will be presented in terms
of relative risk, etc., rather than in terms of the param-
eters of the penetrance model, to make the interpretation
more straightforward.
Simulation studies were performed to examine the
power of marker-disease association studies for simple
Mendelian disorders and for a range of more complex
models of disease inheritance. In the case of a purely
recessive disease ( , , and ), thef p 1 f p 0 f p 0DD DN NN
power of association methods to detect a disease locus
is high, as expected, and is 10.9 when the sample size
exceeds 50 for both cases and controls (fig. 3). For a
purely dominant disease ( , , andf p 1 f p 1 f pDD DN NN
), association studies are less powerful, but the power0
consistently increases with increasing sample sizes (fig.
3). For both sets of results shown in figure 3, the pa-
rameters , , and were used to6N p 10 rp 0.01 sp 00
perform the simulations, and was chosen to′T p 840
satisfy . A total of 5,000 replicates were usedE(p)p 0.1
to compute the expected power.
For more-general models of disease inheritance, given
, f, and , an additive model is assumed, andE(p) RDD
penetrance parameters are calculated using equation (2).
The power of association studies is plotted against the
relative risk of a disease. The parameters ,6N p 100
, , and were used for therp 0.01 n p 100 n p 100D N
simulations. Two different average present-day popu-
lation frequencies of a disease mutation were considered:
a relatively high frequency of 0.1 and a relatively low
frequency of 0.01. The age of the disease mutation was
chosen such that the mean frequency would be equal to
the present-day population frequency—either 840 or
600 generations (for frequencies of 0.1 and 0.01, re-
spectively) for a neutral disease mutation (fig. 4) or 780
or 560 generations (for frequencies of 0.1 and 0.01,
respectively) for a disease mutation under selection with
(results [not shown] are virtually identical tosp 0.001
those shown in fig. 4). Figure 5 shows the results when
the simulation parameters used to generate figure 4 are
again used, but with a larger sample size ( andn p 500D
, instead of and ). Forn p 500 n p 100 n p 100N D N
sample sizes of and , the power ton p 100 n p 100D N
detect an association, computed by using the markers at
three chromosomal intervals, is moderately higher for a
more frequent disease than for a less frequent disease,
and the power is similar, independent of whether mark-
ers in any of the three intervals are used, especially for
a less frequent disease (fig. 4). Selection appeared to have
little effect on the power. The results shown in figure 5
suggest that sample size can greatly affect the power of
marker-disease association studies; much greater power
is achieved if sample size is increased. This is true for
both common and rare diseases.
The method we present focuses on a single disease
locus. Allelic and locus heterogeneity are incorporated
into the model in a vague manner through the pheno-
copy probability. It is straightforward to simulate two
or more disease mutations of the same gene (allelic het-
erogeneity) with the use of our methodology by sim-
ulating multiple disease-locus genealogies. One could
then use an expanded penetrance model (e.g., with six
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Figure 5 Expected power, as a function of genotype relative risk,
of an association study to detect a neutral disease-associated mutation,
computed by using markers positioned in three different chromosomal
intervals, with average distances of 1 kb (v1), 10 kb (v2), or 100 kb
(v3) from the disease locus. Power was estimated using simulated sam-
ples with and . A, Expected power, with an averagen p 500 n p 500D N
present-day population frequency of the disease mutation of pp
and a mutation age of 840 generations. B, Expected power, with0.1
an average present-day population frequency of the disease mutation
of and a mutation age of 600 generations.pp 0.01
parameters for two disease-risk alleles). Similarly, one
could model disease-locus heterogeneity (for unlinked
loci) by using a quantitative genetic model that allows
for epistasis among two or more disease loci to obtain
the probability distribution of multilocus genotypes in
cases and controls and then by independently simulating
each locus in cases and controls.
Another way the model could be extended would be
to allow population genotype frequencies to deviate
from Hardy-Weinberg equilibrium proportions by in-
corporating an inbreeding coefficient. This would be use-
ful for simulating small populations with high levels of
consanguineous matings, for example. Our method con-
ditions on the disease-mutation age and then simulates
the present-day frequency. To condition on frequency and
age, we use rejection sampling; the user specifies an in-
terval for the population frequency of the disease mu-
tation, and only those simulated data sets for which the
frequency is in this interval are accepted. Although tech-
nically correct, this can be computationally inefficient,
and alternative approaches might instead either condi-
tion on frequency and generate random ages via the
simulation or condition on both frequency and age. The
simulation method of Spencer and Coop (2004) con-
ditions on the frequency of the disease mutation and
samples from the distribution of mutation ages, taking
advantage of the reversibility property of the diffusion
process (Griffiths 2003). The method assumes that pop-
ulation size is constant, however, and it cannot be easily
extended to model growing populations.
A final problem in simulating case-control studies is
how to correct for marker ascertainment bias. In many
instances, markers are prescreened for polymorphisms
by using a sample of unrelated normal individuals; a
subset of these prescreened polymorphic markers is then
screened in cases and controls. We modeled ascertain-
ment bias by assuming that a random subset of markers
is chosen in an interval from the total set of polymorphic
markers in the interval (in sampled cases and controls).
One could make this procedure slightly more realistic
by assuming that the markers are chosen from those sites
that are polymorphic in an expanded sample of “nor-
mal” chromosomes (rather than from the present sample
of normal and disease chromosomes). In our opinion,
power analyses based on computer simulations of pop-
ulation samples, such as those proposed here, are more
reliable for predicting when a particular study design
will have low power than for predicting when the design
will have high power. This is because we expect impor-
tant (and perhaps unidentified) factors that have not
been included in the model to be more likely, a priori,
to reduce the power than to increase it.
The program GeneArtisan, written in the C lan-
guage, is available as either a command-line program or
a crossplatform graphical interface program for Linux,
Windows, and Mac OS X. The program can be down-
loaded from authors’ Web site.
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